Bioage Labs, Stock Analysis
| BIOA Stock | 19.70 0.63 3.30% |
BioAge Labs, is overvalued with Real Value of 17.59 and Hype Value of 20.11. The main objective of BioAge Labs, stock analysis is to determine its intrinsic value, which is an estimate of what BioAge Labs, is worth, separate from its market price. There are two main types of BioAge Labs,'s stock analysis: fundamental analysis and technical analysis.
The BioAge Labs, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BioAge Labs,'s ongoing operational relationships across important fundamental and technical indicators.
BioAge |
BioAge Stock Analysis Notes
About 33.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 5.4. BioAge Labs, had not issued any dividends in recent years. BioAmber Inc., an industrial biotechnology company, produces and sells renewable chemicals worldwide. BioAmber Inc. was founded in 2008 is headquartered in Montreal, Canada. BioAmber operates under Chemicals classification in USA and traded on OTC Market. It employs 85 people. For more info on BioAge Labs, please contact Kristen Fortney at 510 806 1445 or go to https://bioagelabs.com.BioAge Labs, Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BioAge Labs,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BioAge Labs, or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| BioAge Labs, had very high historical volatility over the last 90 days | |
| BioAge Labs, has high likelihood to experience some financial distress in the next 2 years | |
| BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
BioAge Labs, Environmental, Social, and Governance (ESG) Scores
BioAge Labs,'s ESG score is a quantitative measure that evaluates BioAge Labs,'s performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of BioAge Labs,'s operations that may have significant financial implications and affect BioAge Labs,'s stock price as well as guide investors towards more socially responsible investments.
BioAge Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 674.12 M.BioAge Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.46) | (2.34) | |
| Return On Capital Employed | 1.50 | 1.58 | |
| Return On Assets | (2.46) | (2.34) | |
| Return On Equity | 0.37 | 0.39 |
Technical Drivers
As of the 27th of November, BioAge Labs, shows the Mean Deviation of 4.1, downside deviation of 5.76, and Risk Adjusted Performance of 0.0523. BioAge Labs, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioAge Labs, Price Movement Analysis
The output start index for this execution was three with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioAge Labs, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioAge Labs,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioAge Labs, Predictive Daily Indicators
BioAge Labs, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioAge Labs, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioAge Labs, Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F3 | 4th of October 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 30th of September 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
BioAge Labs, Forecast Models
BioAge Labs,'s time-series forecasting models are one of many BioAge Labs,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioAge Labs,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioAge Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioAge Labs, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioAge shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioAge Labs,. By using and applying BioAge Stock analysis, traders can create a robust methodology for identifying BioAge entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (6.15) | (6.46) | |
| Operating Profit Margin | (6.63) | (6.96) | |
| Net Loss | (5.91) | (6.21) | |
| Gross Profit Margin | (0.44) | (0.47) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioAge Labs, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for BioAge Stock analysis
When running BioAge Labs,'s price analysis, check to measure BioAge Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs, is operating at the current time. Most of BioAge Labs,'s value examination focuses on studying past and present price action to predict the probability of BioAge Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs,'s price. Additionally, you may evaluate how the addition of BioAge Labs, to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |